Your browser doesn't support javascript.
loading
Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trial.
Zhuravel, Sergey V; Khmelnitskiy, Oleg K; Burlaka, Oleg O; Gritsan, Alexey I; Goloshchekin, Boris M; Kim, Seieun; Hong, Ka Young.
Afiliación
  • Zhuravel SV; State Budgetary Healthcare Institution "N.V. Sklifosovsky Research Institute for Emergency Medicine of Health Department of Moscow", Russia.
  • Khmelnitskiy OK; St Petersburg State Budgetary Health Pokrovskaya City Hospital, St Petersburg, Russia.
  • Burlaka OO; St Petersburg State Budgetary Healthcare Institution "City Aleksandrovskaya Hospital", St Petersburg, Russia.
  • Gritsan AI; V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Regional State Budgetary Healthcare Institution, "Krasnoyarsk Regional Clinical Hospital", Krasnoyarsk, Russia.
  • Goloshchekin BM; St Petersburg State Budget Healthcare Institution City Hospital 15, St Petersburg, Russia.
  • Kim S; Chong Kun Dang (CKD) Pharm., Seoul, South Korea.
  • Hong KY; Chong Kun Dang (CKD) Pharm., Seoul, South Korea.
EClinicalMedicine ; 41: 101169, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34723164
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: EClinicalMedicine Año: 2021 Tipo del documento: Article País de afiliación: Rusia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: EClinicalMedicine Año: 2021 Tipo del documento: Article País de afiliación: Rusia